The European Medicines Agency (EMA) is evaluating an application for the use of a booster dose of Spikevax in people aged 12 years and older.
List view / Grid view
European Centre for Disease Prevention and Control (ECDC)
EMA begins evaluating the application for a booster dose of Comirnaty® in adults to be given six months after the second dose.
Under a new initiative, the EMA will monitor on the safety of marketed COVID-19 vaccines while the ECDC monitors their effectiveness in Europe.
The EMA has released a statement on its efforts to support the development of a treatment for the novel coronavirus (2019-nCoV).
12 May 2017 | By Niamh Marriott, Junior Editor
From diagnosis of HIV to successful viral suppression: this new ECDC report summarises key findings concerning and the Continuum of HIV Care in Europe...
18 November 2015 | By Victoria White
Survey results released by the ECDC show that the situation continues to worsen with regard to the spread of CPE in the EU, with 3 countries reporting an endemic situation...